Background: Extracorporeal membrane oxygenation (ECMO) has been used for decades, but optimal anticoagulation control remains unknown. This study aimed to compare shorter target activated coagulation time (ACT) criteria with the usual ACT in terms of complications.

When patients with severe respiratory failure are treated with venovenous extracorporeal membrane oxygenation (VV-ECMO), severe pulmonary hypertension due to right ventricular (RV) failure is possible. This is a serious complication that requires immediate therapeutic intervention. We report an extraordinary experience of additional venoarterial extracorporeal membrane oxygenation (VA-ECMO) sup...

Background and Objective: The management of large mediastinal tumors requires a complex multidisciplinary approach, particularly in the perioperative setting due to increased risk hemodynamic compromise. utilization extracorporeal membrane oxygenation (ECMO) provides useful adjunct surgical for biopsy resection these masses. objective this article is review indications implementation ECMO disease

The role of extracorporeal membrane oxygenation (ECMO) in the treatment of the acute respiratory distress syndrome (ARDS) is controversial, notwithstanding the recent publication of the results of the CESAR (Conventional Ventilation or ECMO for Severe Adult Respiratory Failure) trial. Using Bayesian meta-analytic methods from three randomised controlled trials (RCTs) of ECMO in ARDS, we estimat...

Purpose: To evaluate risk factors for bleeding events in coronavirus disease 2019 (COVID-19) patients on extracorporeal membrane oxygenation (ECMO) and to share the initial results of transcatheter arterial embolization (TAE) hemostasis.

Introduction: Veno-venous extracorporeal membrane oxygenation (VV ECMO) is an indicated treatment for severe acute respiratory distress syndrome (ARDS) refractory to conventional medical treatment. Severe ARDS a common complication of CoVID-19 infection. Subsequently, the efficacy VV ECMO in patients must be investigated. resource-intensive modality, meaning that its use reserved with robust in...

Background: The use of extracorporeal membrane oxygenation (ECMO) for the management severe acute respiratory distress syndrome (ARDS) secondary to 2019 coronavirus (COVID-19) has been described. However, this complex patient population evolved over course pandemic, likely contributing variable outcomes. We report our adaptive experience managing patients on venovenous (VV) ECMO from a single i...

We report a case of H7N9 avian influenza pneumonia in a pregnant woman who developed acute respiratory distress syndrome (ARDS) managed with extracorporeal membrane oxygenation (ECMO). A 29-year-old, 27 week pregnant woman developed rapidly progressive pneumonia with bilateral infiltrates on chest x-ray and was confirmed to have influenza A (H7N9) infection. Her condition deteriorated and she d...

Pulmonary contusion and acute respiratory distress syndrome (ARDS) is a common manifestation in polytraumatic patients. Although mechanical ventilation is still the first choice of treatment, a group of patients are still unable to maintain their oxygenation. The role of extracorporeal membrane oxygenation (ECMO) has been more clarified when the lung is extensively damaged and when conventional...

Introduction: Extracorporeal membrane oxygenation (ECMO) is a support therapy that can be used in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and refractory hypoxemia, despite optimal management. However, ECMO may responsible for synergic effect the proposed mechanism of viral associated hyperinflammation.